Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market
January 06, 2015 at 12:21 PM EST
The biotech sector's expected 2015 earnings growth of 19 percent will far outpace the broader market while drug reimbursement ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.